$42.99
-0.02-0.05%
À la clôture: Nov 13, 4:00 PM EST
$42.99
-0.02-0.05%
Pré-ouverture: 7:56 AM EST

The average analyst price target for LB Pharmaceuticals is $54.09, 25.8% above the current price. Of 11 analysts, 10 rate it Buy and 1 Hold. Targets range from $34 to $80. The latest change came on Oct 9, 2026, when Canaccord Genuity initiated coverage of LB Pharmaceuticals with a Buy rating and a $65 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months